 Fibrinolytic Agents
"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1999 | 0 | 3 | 3 | | 2000 | 1 | 1 | 2 | | 2001 | 4 | 0 | 4 | | 2002 | 4 | 1 | 5 | | 2003 | 3 | 3 | 6 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 1 | 4 | | 2006 | 3 | 2 | 5 | | 2007 | 3 | 2 | 5 | | 2008 | 8 | 2 | 10 | | 2009 | 9 | 3 | 12 | | 2010 | 8 | 7 | 15 | | 2011 | 7 | 4 | 11 | | 2012 | 5 | 2 | 7 | | 2013 | 3 | 3 | 6 | | 2014 | 2 | 4 | 6 | | 2015 | 8 | 1 | 9 | | 2016 | 4 | 2 | 6 | | 2017 | 2 | 1 | 3 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Naragum V, Jindal G, Miller T, Kole M, Shivashankar R, Merino JG, Cole J, Chen R, Kohler N, Gandhi D. Functional Independence After Stroke Thrombectomy Using Thrombolysis In Cerebral Infarction Grade 2c: A New Aim of Successful Revascularization. World Neurosurg. 2018 Nov; 119:e928-e933.
-
Fisher M, Furie K. Practicing Evidence-Based Stroke Medicine. Stroke. 2017 10; 48(10):2647-2649.
-
Raschke RA, Gallo T, Curry SC, Whiting T, Padilla-Jones A, Warkentin TE, Puri A. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Haemost. 2017 08; 15(8):1640-1645.
-
McDermott M, Lisabeth LD, Baek J, Adelman EE, Garcia NM, Case E, Campbell MS, Morgenstern LB, Zahuranec DB. Sex Disparity in Stroke Quality of Care in a Community-Based Study. J Stroke Cerebrovasc Dis. 2017 Aug; 26(8):1781-1786.
-
Domino JS, Baek J, Meurer WJ, Garcia N, Morgenstern LB, Campbell M, Lisabeth LD. Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project. Neurology. 2016 Nov 22; 87(21):2184-2191.
-
Bradford MA, Lindenauer PK, Walkey AJ. Practice patterns and complication rates of thrombolysis for pulmonary embolism. J Thromb Thrombolysis. 2016 Oct; 42(3):313-21.
-
Rossi KC, Liang JW, Wilson N, Tuhrim S, Dhamoon MS. More Time Is Taken to Administer Tissue Plasminogen Activator in Ischemic Stroke Patients with Earlier Presentations. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):70-73.
-
Carandang RA. Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy. JAMA Neurol. 2016 Mar; 73(3):265-7.
-
Goyal M, Yu AY, Menon BK, Dippel DW, Hacke W, Davis SM, Fisher M, Yavagal DR, Turjman F, Ross J, Yoshimura S, Miao Z, Bhatia R, Almekhlafi M, Murayama Y, Sohn SI, Saver JL, Demchuk AM, Hill MD. Endovascular Therapy in Acute Ischemic Stroke: Challenges and Transition From Trials to Bedside. Stroke. 2016 Feb; 47(2):548-53.
-
Gremmel T, Yanachkov IB, Yanachkova MI, Wright GE, Wider J, Undyala VV, Michelson AD, Frelinger AL, Przyklenk K. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Arterioscler Thromb Vasc Biol. 2016 Mar; 36(3):501-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|